Pranlukast hydrate in the treatment of pediatric bronchial asthma
Shigemi Yoshihara Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan Abstract: Pranlukast hydrate is a potent, selective, orally active, cysteinyl leukotriene antagonist that binds at the type 1 receptor. It is used as a 10% dry syrup to treat asthma and allergic rhinitis in pediatr...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Pediatric Health, Medicine and Therapeutics |
Online Access: | http://www.dovepress.com/pranlukast-hydrate-in-the-treatment-of-pediatric-bronchial-asthma-a13612 |